| Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus PH Mygind, RL Fischer, KM Schnorr, MT Hansen, CP Sönksen, ... Nature 437 (7061), 975-980, 2005 | 805 | 2005 |
| Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples H Hasman, D Saputra, T Sicheritz-Ponten, O Lund, CA Svendsen, ... Journal of clinical microbiology 52 (1), 139-146, 2014 | 593 | 2014 |
| Interplay in the selection of fluoroquinolone resistance and bacterial fitness LL Marcusson, N Frimodt-Møller, D Hughes PLoS pathogens 5 (8), e1000541, 2009 | 385 | 2009 |
| Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases AG Jensen, CH Wachmann, F Espersen, J Scheibel, P Skinhøj, ... Archives of Internal Medicine 162 (1), 25-32, 2002 | 367 | 2002 |
| Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance MB Kerrn, T Klemmensen, N Frimodt-Møller, F Espersen Journal of antimicrobial chemotherapy 50 (4), 513-516, 2002 | 334 | 2002 |
| In Vivo Transfer of the vanA Resistance Gene from an Enterococcus faecium Isolate of Animal Origin to an E. faecium Isolate of Human Origin in the Intestines of … CH Lester, N Frimodt-Møller, TL Sørensen, DL Monnet, AM Hammerum Antimicrobial agents and chemotherapy 50 (2), 596-599, 2006 | 295 | 2006 |
| Presence of erm gene classes in Gram-positive bacteria of animal and human origin in Denmark LB Jensen, N Frimodt-Møller, FM Aarestrup FEMS microbiology letters 170 (1), 151-158, 1999 | 287 | 1999 |
| Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage A Huttner, J Bielicki, MN Clements, N Frimodt-Møller, AE Muller, ... Clinical Microbiology and Infection 26 (7), 871-879, 2020 | 269 | 2020 |
| Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork TL Sørensen, M Blom, DL Monnet, N Frimodt-Møller, RL Poulsen, ... New England Journal of Medicine 345 (16), 1161-1166, 2001 | 263 | 2001 |
| Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990 AG Jensen, F Espersen, P Skinhøj, VT Rosdahl, N Frimodt-Møller Journal of infection 34 (2), 113-118, 1997 | 239 | 1997 |
| Evaluation of a cefoxitin 30 µg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus R Skov, R Smyth, M Clausen, AR Larsen, N Frimodt-Møller, ... Journal of Antimicrobial Chemotherapy 52 (2), 204-207, 2003 | 231 | 2003 |
| Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T Benfield, F Espersen, N Frimodt-Møller, AG Jensen, AR Larsen, ... Clinical microbiology and infection 13 (3), 257-263, 2007 | 224 | 2007 |
| Bacteremic Staphylococcus aureus spondylitis AG Jensen, F Espersen, P Skinhøj, N Frimodt-Møller Archives of internal medicine 158 (5), 509-517, 1998 | 223 | 1998 |
| In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model M Arendrup, T Horn, N Frimodt-Møller Infection 30, 286-291, 2002 | 222 | 2002 |
| Risk factors for hospital-acquired Staphylococcus aureus bacteremia AG Jensen, CH Wachmann, KB Poulsen, F Espersen, J Scheibel, ... Archives of internal medicine 159 (13), 1437-1444, 1999 | 220 | 1999 |
| Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009 P Zarb, B Amadeo, A Muller, N Drapier, V Vankerckhoven, P Davey, ... Journal of Antimicrobial Chemotherapy 66 (2), 443-449, 2011 | 210 | 2011 |
| Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark BL Røder, DA Wandall, N Frimodt-Møller, F Espersen, P Skinhøj, ... Archives of internal medicine 159 (5), 462-469, 1999 | 210 | 1999 |
| Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies H Hvidberg, C Struve, KA Krogfelt, N Christensen, SN Rasmussen, ... Antimicrobial agents and chemotherapy 44 (1), 156-163, 2000 | 201 | 2000 |
| Clinical manifestations and molecular epidemiology ofVibrio vulnificus infections in Denmark A Dalsgaard, N Frimodt-Møller, B Bruun, L Høi, JL Larsen European Journal of Clinical Microbiology and Infectious Diseases 15, 227-232, 1996 | 198 | 1996 |
| Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence MC Arendrup, E Mavridou, KL Mortensen, E Snelders, N Frimodt-Møller, ... PLoS one 5 (4), e10080, 2010 | 196 | 2010 |
